Cargando…
Developments and challenges in neoadjuvant therapy for locally advanced pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) remains a significant public health challenge and is currently the fourth leading cause of cancer-related mortality in developed countries. Despite advances in cancer treatment, the 5-year survival rate for patients with PDAC remains less than 5%. In recent ye...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514760/ https://www.ncbi.nlm.nih.gov/pubmed/37744290 http://dx.doi.org/10.3748/wjg.v29.i35.5094 |